Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Evaluation of Docetaxel and Vinorelbine Plus Sargramostim in Patients With Metastatic Malignant Melanoma

NCT00256282 is registered in ClinicalTrials.gov with John P. Fruehauf as lead sponsor.

NCT NCT00256282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00256282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Evaluation of Docetaxel and Vinorelbine Plus Sargramostim in Patients With Metastatic Malignant Melanoma
Lead sponsor
John P. Fruehauf
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
August 31, 2012
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma